Filippo Caraci is Full Professor of Pharmacology at University of Catania and Chief of the Unit of Translational Neuropharmacology and Translational Neurosciences at IRCCS Associazione Oasi Maria SS., Department of the Laboratories, Troina, Italy. Included in Stanford/Elsevier's Top 2% Scientist Rankings. He has worked in the field of Neuropharmacology focusing his attention on the neurobiology of depression and Alzheimer’s disease with the aim to identify new pharmacological targets. Dr. Caraci's research has provided contributions to the understanding of the physiology and pharmacology of Transforming-Growth-Factor-ß1 (TGF-ß1) and its role in the pathophysiology of Depression and Alzheimer’s disease.He has also coordinated different observational studies in cognitive disorders with the aim to validate in vivo the same pharmacological targets identified in preclinical studies. His work has been published in journals among which Nature Medicine, Alzheimer’s Disease & Dementia, Trends in Pharmacological Sciences, Journal of Neuroscience, Neurobiology of Disease, Neurobiology of Aging, Neuropharmacology Pharmacological Research, Molecular Pharmacology, CNS Neuroscience & Therapeutics